Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2015 November;81(11) > Minerva Anestesiologica 2015 November;81(11):1244-61

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Cite this article as
Share

 

REVIEWS   Free accessfree

Minerva Anestesiologica 2015 November;81(11):1244-61

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Complications of immunosuppressive agents therapy in transplant patients

Reske A. P. 1, Reske A. W. 2, Metze M. 3

1 Fachkrankenhaus Coswig GmbH, Division of Anesthesiology and Intensive Care Medicine, Coswig, Germany; 2 Department of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany; 3 Division of Cardiology and Angiology, Department of Internal Medicine, Neurology and Dermatology, University Hospital Leipzig, Leipzig, Germany


PDF


Solid organ transplantation remains the gold standard for the treatment of end-stage organ dysfunction and saves thousands of lives. Besides the progress of surgery, advances in understanding transplant physiology, immunology and the development of immunosuppressive drugs lead to improved short- and long-term survival. Transplantation is offered to an increasing number of patients with higher age and comorbidities. Approximately one third of organ recipients require hospital readmission after transplantation because of a multitude of clinical problems related to immunosuppressive therapy. We review the current knowledge on typical complications associated with immunosuppressants with emphasis on the intensivist’s perspective.

top of page